Clinical Features and Outcomes of Monobacterial and Polybacterial Episodes of Ventilator-Associated Pneumonia Due to Multidrug-Resistant <i>Acinetobacter baumannii</i>
Multidrug-resistant <i>A. baumannii</i> (MDRAB) VAP has high morbidity and mortality, and the rates are constantly increasing globally. Mono- and polybacterial MDRAB VAP might differ, including outcomes. We conducted a single-center, retrospective (January 2014–December 2016) study in th...
Main Authors: | Dalia Adukauskiene, Ausra Ciginskiene, Agne Adukauskaite, Despoina Koulenti, Jordi Rello |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/11/7/892 |
Similar Items
-
Clinical Features and Outcomes of VAP Due to Multidrug-Resistant <i>Klebsiella</i> spp.: A Retrospective Study Comparing Monobacterial and Polybacterial Episodes
by: Dalia Adukauskiene, et al.
Published: (2023-06-01) -
Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible <i>Acinetobacter baumannii</i> VAP: Clinical, Pharmacokinetic and Microbiome Features
by: Gennaro De Pascale, et al.
Published: (2023-01-01) -
Co-Administration of High-Dose Nebulized Colistin for <i>Acinetobacter baumannii</i> Bacteremic Ventilator-Associated Pneumonia: Impact on Outcomes
by: Ioannis Andrianopoulos, et al.
Published: (2024-02-01) -
Preclinical Assessment of Bacteriophage Therapy against Experimental <i>Acinetobacter baumannii</i> Lung Infection
by: Sandra-Maria Wienhold, et al.
Published: (2021-12-01) -
Ventilator-Associated Pneumonia due to Drug-Resistant <i>Acinetobacter baumannii</i>: Risk Factors and Mortality Relation with Resistance Profiles, and Independent Predictors of In-Hospital Mortality
by: Aušra Čiginskienė, et al.
Published: (2019-02-01)